Remote Behavioral Intervention Effective in Lowering Blood Pressure Variability

A new study reveals that remotely delivered behavioral interventions can effectively reduce systolic blood pressure variability, fostering better blood pressure control and reducing cardiovascular risks.
A recent study published in Scientific Reports has demonstrated that remotely delivered behavioral interventions can significantly reduce the variability of systolic blood pressure, known as the coefficient of variation (BPCoV). This research, conducted by Dr. Eyal Shemesh and colleagues from the Icahn School of Medicine at Mount Sinai in New York City, offers promising insights into managing blood pressure fluctuations through remote patient engagement.
The study involved a single-arm prospective proof-of-concept trial with patients exhibiting high blood pressure variability (BPCoV over 10%), identified through electronic health record reviews. Participants were provided with a blood pressure monitor and received behavioral interventions remotely over a three-month period. Out of 551 screened patients, 107 demonstrated high BPCoV, and 25 opted to participate in the intervention.
Results showed that the average BPCoV decreased from 12.96 in the six months prior to enrollment to 7.02 during the intervention, indicating a substantial reduction in blood pressure variability. Improvements were also noted across other variability measures, with data remaining consistent across different measurement methods, including clinic and home readings.
Dr. Shemesh emphasized the importance of monitoring blood pressure over time, rather than solely focusing on single-visit readings. The study highlights that remote engagement can effectively help patients stabilize their blood pressure, which is crucial for reducing cardiovascular risks associated with blood pressure fluctuations.
This innovative approach demonstrates that patients can be empowered to participate in their health management remotely, potentially transforming hypertension care. For more details, the full study can be accessed via source.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Evolocumab Shows No Benefit in Preventing Vein Graft Disease After Coronary Bypass Surgery, Major Trial Finds
A recent trial reveals that evolocumab, despite significantly lowering LDL cholesterol, does not reduce vein graft disease rates after coronary artery bypass surgery, pointing to the need for novel treatment strategies.
Enhancing Prenatal Care to Reduce Low Birth Weight Risks
A new study highlights the critical role of increased prenatal checkups in improving birth weights and reducing low birth weight cases in The Gambia, supporting better neonatal health outcomes.
Increasing Rates of Autoimmune Conditions in Expectant Mothers in the UK Since 2000
A recent study reports a notable increase in autoimmune diseases among pregnant women in the UK since 2000, highlighting important implications for maternal healthcare and disease management.
Innovative Dental Flosser with Built-In Stress Monitoring Sensor
A groundbreaking dental floss pick now features a built-in sensor capable of monitoring cortisol levels, offering a convenient and non-invasive method for at-home stress detection.